Description

A vitamin A-based medication is indicated for the adjunctive treatment of irritant dermatitis. Irritant contact dermatitis is more common and is caused by various skin-irritating and inflammatory substances. The rash can be treated topically, especially with the use of a skin ointment. Vitamin A was first isolated from the retina, where it got its name "retinol."

Ingredients:

Synthetic vitamin A (concentrate) – oily form 200,000 IU per 100 g of ointment. Excipients: macrogol 400, macrogol 4000, polysorbate 80. Other names for vitamin A: retinol, retina, retinyl acetate, retinyl palmitate, retinyl phosphate.

A313 should not be used: Do not use A313 if you have a history of hypersensitivity to any component, infected dermatoses, or exuding dermatoses. Vitamin A is found in many medications, some of which are available for self-medication: avoid combining them with A313, as vitamin A overdose can cause serious side effects. Risk of A-hypervitaminosis: A313 should not be applied to large areas of skin, severely damaged skin (burned skin, open wounds), mucous membranes, premature infants, infants, or during prolonged treatment.

• Ärge kasutage A313  kui teil on anamneesis ülitundlikkus ühe komponendi suhtes, nakatunud dermatoosid, väljaheidetud dermatoosid.
• A-vitamiini leidub paljudes ravimites, millest mõned on saadaval iseravimiseks: vältige nende kombineerimist A313-ga, kuna A-vitamiini üleannustamine võib põhjustada tõsiseid kõrvaltoimeid.
• A-hüpervitaminoosi oht: A313 ei tohi kanda suurele nahapinnale, väga kahjustatud nahale ( põlenud nahk, avatud haavad), limaskestale, enneaegsetel imikutel, väikel või pikaajalise ravi ajal.